Effects of palmitate on insulin secretion and exocytotic proteins in islets of diabetic Goto-Kakizaki rats

Pancreas

Volumn 34, Issue 3, 2007, Pages 359-363

  Östenson, Claes Göran ^a,c   Chen, Jie ^a   Sheu, Laura ^b   Gaisano, Herbert Y ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF TORONTO   (Canada)

^c Department of Molecular Medicine and Surgery   (Sweden)

Author keywords

Exocytosis; Fatty acids; Glucotoxicity; Insulin secretion; Lipotoxicity; Pancreatic islets; Type 2 diabetes

Indexed keywords

ACTIN; ARGININE; INSULIN; MUNC18 PROTEIN; N ETHYLMALEIMIDE SENSITIVE FACTOR; PALMITIC ACID; SYNAPTOBREVIN 2; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DIABETES MELLITUS; EXOCYTOSIS; GLUCOSE BLOOD LEVEL; IMMUNOBLOTTING; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS;

ANIMALS; EXOCYTOSIS; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; PALMITIC ACID; PROTEINS; RATS; RATS, MUTANT STRAINS;

EID: 34247152956     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3180304825     Document Type: Article

References (26)

1. Gerich JE. The genetic basis is type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev. 1998;19:491-503.
2. Kahn RB. Type 2 diabetes, when insulin secretion fails to compensate for insulin resistance. Cell. 1998;92:593-596.
3. Ostenson CG. The pathophysiology of type 2 diabetes mellitus: an overview. Acta Physiol Scand. 2001;171:241-247.
4. Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care. 1990;13:610-630.
5. Leahy JL, Weir GC. β-Cell dysfunction in hyperglycemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level. Diabetologia. 1991;34:640-647.
6. DeFronzo RA. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract. 2004;143(suppl):9-21.
7. Paolisso G, Gambardella A, Amato L, et al. Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia. 1995;38:1295-1299.
8. Hagman DK, Hays LB, Parazzoli SD, et al. Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans. J Biol Chem. 2005;280:32413-32418.
9. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology. 2003;144:5159-5165.
10. Gerber SH, Sudhof TC. Molecular determinants of regulated exocytosis. Review. Diabetes. 2002;51(suppl 1):S3-S11.
11. Wheeler MB, Sheu L, Ghai M, et al. Characterization of SNARE protein expression in A-cell lines and pancreatic islets. Endocrinology. 1996;137:1340-1348.
12. Nagamatsu S, Nakamichi Y, Yamamura C, et al. Decreased expression of t-SNARE syntaxin 1 and SNAP25 in pancreatic β cells is involved in impaired insulin secretion from diabetic GK rat islets; restoration of decreased t-SNARE proteins improves impaired insulin secretion. Diabetes. 1999;48:2367-2373.
13. Chan CB, MacPhail RM, Sheu L, et al. A-Cell hypertrophy in fa/fa rats is associated with basal glucose hypersensitivity and reduced SNARE protein expression. Diabetes. 1999;48:997-1005.
14. Gaisano HY, Ostenson CG, Sheu L, et al. Abnormal expression of pancreatic islet exocytotic soluble N-ethylmaleimide-sensitive factor attachment protein receptors in Goto-Kakizaki rats is partially restored by phlorizin treatment and accentuated by high glucose treatment. Endocrinology. 2002;143:4218-4226.
15. Zhang W, Khan A, Ostenson CG, et al. Down-regulated expression of exocytotic proteins in pancreatic islets of diabetic GK rats. Biochem Biophys Res Commun. 2002;291:1038-1044.
16. Ostenson CG, Gaisano HY, Sheu L, et al. Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. Diabetes. 2006;55:435-440.
17. Zhou YP, Ostenson CG, Ling ZC, et al. Deficiency of pyruvate dehydrogenase activity in pancreatic islets of diabetic GK rats. Endocrinology. 1995;136:3546-3551.
18. Shang W, Yasuda K, Takahashi A, et al. Effect of high dietary fat on insulin secretion in genetically diabetic Goto-Kakizaki rats. Pancreas. 2002;25:393-399.
19. Briaud I, Kelpe CL, Johnson LM, et al. Differential effects of hyperlipidemia on insulin secretion in islets of Langerhans from hyperglycemic versus normoglycemic rats. Diabetes. 2002;51:662-668.
20. Ostenson CG, Khan A, Abdel-Halim SM, et al. Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat. Diabetologia. 1993;36:3-8.
21. Ostenson CG, Grill V. Differences in long-term effects of L-glutamine and D-glucose on insulin release from rat pancreatic islets. Mol Cell Endocrinol. 1986;45:215-221.
22. Herbert V, Lau KS, Gottlieb CW, et al. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965;25:1375-1384.
23. Huang XH, Wheeler MB, Kang HY, et al. Truncated SNAP-25 (1-197), like botulinum neurotoxin A inhibits insulin secretion from HIT-T15 insulinoma cells. Mol Endocrinol. 1998;12:1060-1070.
24. Daniel S, Noda M, Straub SG, et al. Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion. Diabetes. 1999;48:1686-1690.
25. Okamoto Y, Ishida H, Tsuura Y, et al. Hyperresponse in calcium-induced insulin release from electrically permeabilized pancreatic islets of diabetic GK rats and its defective augmentation by glucose. Diabetologia. 1995;38:772-778.
26. Szule JA, Jarvis SE, Hibbert JE, et al. Calcium-triggered membrane fusion proceeds independently of specific presynaptic proteins. J Biol Chem. 2003;278:24251-24254.